Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction

← catalyst calendar

NCT02446249

Sponsored by MeiraGTx, LLC (industry) · MGTX — their whole pipeline →. With National Institute of Dental and Craniofacial Research (NIDCR).

Phase
Phase 1
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
17actual
Sites
1
Country
United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2015-05-04not statedWhen the study began enrolling
Primary completionJul 2026estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completionJul 2026estimatedThe whole study's end, after follow-up
First posted2015-05-18estimatedWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-09-25actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • Squamous Cell Head and Neck Cancer
  • Radiation Induced Xerostomia
  • Salivary Hypofunction

Intervention

  • Biological: AAV2hAQP1

Primary outcome

what the primary-completion date above is the date OF
Safety of vector
measured 36 months

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · MGTX's whole pipeline · Catalyst calendar · Every registered study · What changed